The Efficacy of Endoscopic Papillary Balloon Dilation for Patients with Acute Biliary Pancreatitis

Background. No study investigated the efficacy and safety of endoscopic papillary balloon dilation (EPBD) for the treatment of acute biliary pancreatitis (ABP). Method. We retrospectively reviewed the effects of EPBD on patients with ABP from February 2003 to December 2012. The general data, finding...

Full description

Saved in:
Bibliographic Details
Published in:Gastroenterology research and practice 2015-01, Vol.2015 (2015), p.1-8
Main Authors: Chiang, Po-Hung, Hsu, Ping-I, Tsai, Wei-Lun, Chen, Wen-Chih, Li, Yun-Da, Wang, E-Ming, Kao, Sung-Shuo, Wang, Kai-Ming, Lin, Kung-Hung, Lin, Huey-Shyan, Tsai, Tzung-Jiun, Lai, Kwok-Hung, Chan, Hoi-Hung, Sun, Wei-Chih, Cheng, Jin-Shiung
Format: Article
Language:English
Subjects:
Analysis
Balloon dilatation
Bile
Care and treatment
Diagnosis
Endoscopy
Health aspects
Methods
Mortality
Pancreas
Pancreatitis
Patient outcomes
Rodents
Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background. No study investigated the efficacy and safety of endoscopic papillary balloon dilation (EPBD) for the treatment of acute biliary pancreatitis (ABP). Method. We retrospectively reviewed the effects of EPBD on patients with ABP from February 2003 to December 2012. The general data, findings of image studies, details of the procedure, and outcomes after EPBD were analyzed. Result. Total 183 patients (male/female: 110/73) were enrolled. The mean age was 65.9 years. Among them, 155 patients had mild pancreatitis. The meantime from admission to EPBD was 3.3 days. Cholangiogram revealed filling defects inside the common bile duct (CBD) in 149 patients. The mean dilating balloon size was 10.5 mm and mean duration of the dilating procedure was 4.3 minutes. Overall, 124 patients had gross stones retrieved from CBD. Four (2.2%) adverse events and 2 (1.1%) intraprocedure bleeding incidents but no procedure-related mortality were noted. Bilirubin and amylase levels significantly decreased after EPBD. On average, patients resumed oral intake within 1.4 days. The clinical parameters and outcomes were similar in patients with different severity of pancreatitis. Conclusion. EPBD can be effective and safe for the treatment of ABP, even in patients presenting with severe disease.
ISSN:1687-6121
1687-630X
DOI:10.1155/2015/575898